Abstract
Nasopharyngeal carcinoma (NPC) is closely associated with Epstein-Barr virus (EBV) infection. It is also characterized by heavy infiltration with non-malignant leucocytes. The EBV-encoded latent membrane protein 1 (LMP1) is believed to play an important role in NPC pathogenesis by virtue of its ability to activate multiple cell signaling pathways which collectively promote cell proliferation and survival, angiogenesis, invasiveness, and aerobic glycolysis. LMP1 also affects cell-cell interactions, antigen presentation, and cytokine and chemokine production. Here, we discuss how LMP1 modulates local immune responses that contribute to the establishment of the NPC tumor microenvironment. We also discuss strategies for targeting the LMP1 protein as a novel therapy for EBV-driven malignancies. © 2021 Lo, Dawson, Lung, Wong and Young.
| Original language | English |
|---|---|
| Article number | 640207 |
| Number of pages | 17 |
| Journal | Frontiers in Oncology |
| Volume | 11 |
| Online published | 25 Feb 2021 |
| DOIs | |
| Publication status | Published - Feb 2021 |
| Externally published | Yes |
Funding
This work was supported by Research Grants Council of Hong Kong (Grant No. HKBU12300117).
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Research Keywords
- Epstein-Barr virus
- latent membrane protein 1
- nasopharyngeal carcinoma
- therapy
- tumor microenvironment
Publisher's Copyright Statement
- This full text is made available under CC-BY 4.0. https://creativecommons.org/licenses/by/4.0/
Fingerprint
Dive into the research topics of 'The Role of EBV-Encoded LMP1 in the NPC Tumor Microenvironment: From Function to Therapy'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver